Log inSign up
UChicago Medicine Comprehensive Cancer Center
15.2K posts
UChicago Medicine Comprehensive Cancer Center profile banner
@UCCancerCenter

UChicago Medicine Comprehensive Cancer Center

@UCCancerCenter
@UChicagoMed Comprehensive Cancer Center designated by @theNCI for 50+ yrs. #NothingWillStopUs #WeAreNCIDesignated uchicagocancer.bsky.social
Chicago, IL
uchicagomedicine.org/cancer
Joined June 2010
1,590
Following
10.1K
Followers
RepliesRepliesRepostsRepostsMediaMedia

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
  • @UCCancerCenter
    UChicago Medicine Comprehensive Cancer Center
    @UCCancerCenter
    13h
    🔥Hot off the press: A new @MolecularCell study reveals that WDR5 broadly binds RNA to reshape the MLL1/KMT2A chromatin-modifying complex, offering insight into how RNA-mediated regulation of chromatin state may influence leukemia development.
    RNA creates a self-destruct switch for cellular machinery linked to leukemia
    From biologicalsciences.uchicago.edu
  • @UCCancerCenter
    UChicago Medicine Comprehensive Cancer Center
    @UCCancerCenter
    15h
    Dr. Muhammad Rafiqul Islam writes about the challenges faced by mid-career oncologists practicing in low- or lower-middle-income countries. ascopost.com/news/august-20… @ASCOPost
    ascopost.com
    The Mid-Career Oncologist in LMIC Regions: Navigating Disparities, Avoiding Burnout, and Delivering...
    To be a mid-career oncologist is to occupy an emotionally and physically taxing space within a trying clinical environment. We may be 10 years and beyond our post-training. We are no longer trainees...
  • @UCCancerCenter
    UChicago Medicine Comprehensive Cancer Center
    @UCCancerCenter
    16h
    A new multicenter GASTRIC consortium study identify that absence of unusual endoscopic findings may be reassuring; masses, thickened folds, and signet ring cell carcinoma indicate higher risk of advanced disease in CDH1 carriers. @SoniaKupfer @UChicagoGI pubmed.ncbi.nlm.nih.gov/42604658/
  • @UCCancerCenter
    UChicago Medicine Comprehensive Cancer Center
    @UCCancerCenter
    17h
    Check out the @NCI's new AI-assisted tool to find a suitable #cancertrial.
    @NCIDirector
    Dr. Anthony Letai
    @NCIDirector
    18h
    I am committed to reducing administrative burdens related to cancer clinical trials. NCI SBIR-funded @themednet is helping with TrialMatch, a new AI-assisted tool that makes it faster and easier for doctors to find trials for their patients. go.nih.gov/uA0Cyg2
    Text on a beige background reads, \"TrialMatch. A better way to find cancer trials. Open, enrolling patients for the patient in front of you. Start a search. Funded by the National Cancer Institute.\"
    1
  • @UCCancerCenter
    UChicago Medicine Comprehensive Cancer Center
    @UCCancerCenter
    18h
    Why do some tumors respond to treatment while others fail? @UChicago researchers developed AI tools to map how tumor cells and their gene activity are organized in the tumor microenvironment, helping predict treatment response. @CellRepMed @UChicagoPath ow.ly/gE0L50ZHkMw